KOSDAQ · 18,850 KRW · As of Aug 26, 2026 close
1Y Close · As of Aug 26, 2026
Mkt Cap
1.6T
PBR
35864.94
52W
11K~138K
Kolon TissueGene operates in the Pharmaceuticals sector.
Legal name: Kolon TissueGene, Inc.
As of the Aug 26, 2026 close, the market capitalization was 1.60 trillion KRW, with a P/B of 35864.94.
These figures can be verified in the DART filing (receipt no. 20260318001341).
Recent Filings
Semi-Annual Report (2026.06)
Large Shareholding Report (General)
Officer/Major Shareholder Ownership Report
Checks
4 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: 3 administrative designation criteria met. [source]
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: Convertible bonds outstanding with 0.02% potential dilution.
Capital Increase: 1 capital-increase filing(s) in the last 180 days. [source]
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: 2 embezzlement/litigation filing(s) in the last 180 days. [source]
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-07 | Large Shareholding Report (General) |
| 2026-08-06 | Officer/Major Shareholder Ownership Report |
| 2026-07-31 | Large Shareholding Report (General) |